Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001349083-08-000008
Filing Date
2008-02-06
Accepted
2008-02-06 15:36:37
Documents
1
Period of Report
2008-02-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 9356
  Complete submission text file 0001349083-08-000008.txt   11557
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCO FINANCIAL GROUP LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019
Business Address C/O SCO FINANCIAL GROUP LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019 212-554-4158
Jeffrey B Davis (Reporting) CIK: 0001349083 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 08581391